15 completed. 15 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 15 |
| Phase 3 | 3 | Completed 3 |
Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR) Colchicine - Chronic Kidney Diseases, Renal Failure | Phase 2 | Completed | Hamilton Health Sciences Corporation | 96 | 2024-11-15 | 2026-08-13 |
| Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis HAV - Renal Failure, End Stage Renal Disease | Phase 2 | Completed | Humacyte, Inc. | 30 | 2019-11-12 | 2024-03-19 |
| HBV Vaccine in Renal Failure Patients Intradermal HBVv with imiquimod, Intradermal HBVv with aqueous cream, Intramuscular HBVv with aqueous cream - Renal Failure | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 94 | 2016-01-01 | 2019-10-22 |
| Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant LCP-Tacro tablets, Prograf - Renal Failure | Phase 2 | Completed | Veloxis Pharmaceuticals | 36 | 2012-11-01 | 2015-07-07 |
| Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis Percutaneous Transluminal Angioplasty (PTA), Paclitaxel Eluting Balloon Angioplasty - Renal Failure | Phase 2 | Completed | University Health Network, Toronto | 32 | 2012-02-01 | 2014-11-17 |
| Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery Erythropoietin zeta, Placebo - Kidney Failure, Renal Failure | Phase 2 | Completed | Region Skane | 75 | 2011-10-01 | 2013-10-25 |
| Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients Lenalidomide and Dexamethasone - Renal Failure, Multiple Myeloma | Phase 2 | Completed | University Health Network, Toronto | 28 | 2010-11-01 | 2017-12-29 |
| Does Nesiritide Provide Renal Protection Nesiritide, Placebo - Renal Failure | Phase 2 | Completed | University of Florida | 37 | 2010-04-01 | 2014-06-06 |
| Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment Midodrine plus Albumin - Cirrhosis, Renal Failure | Phase 2 | Completed | Hospital Clinic of Barcelona | 7 | 2010-02-01 | 2016-08-18 |
| Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill atorvastatin 80 mg per os daily, placebo - Myocardial Infarction, Stroke | Phase 2 / Phase 3 | Completed | University of Alberta | 100 | 2009-04-01 | 2011-12-16 |
| Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients Tacrolimus (Tacro™), Prograf - Kidney Failure, Renal Failure | Phase 2 | Completed | Veloxis Pharmaceuticals | 63 | 2008-09-01 | 2015-05-19 |
| Renal Blood Flow Measurement With Positron Emission Tomography (PET) 62Cu-ethylglyoxal bis(thiosemicarbazone), 15O-water, Positron Emission Tomography - Renal Failure, Renal Artery Stenosis | Phase 2 | Completed | Jeffrey L. Lacy | 30 | 2008-08-01 | 2017-04-19 |
| Hypertonic Saline Solution in Heart Failure NaCl 7,5% (Hypertonic Saline Solution), NaCl 0,9% - Heart Failure, Renal Failure | Phase 2 | Completed | University of Sao Paulo | 34 | 2008-02-01 | 2014-06-10 |
| Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients LCP Tacro (tacrolimus), Prograf - Renal Failure | Phase 2 | Completed | Veloxis Pharmaceuticals | 60 | 2007-07-01 | 2015-07-23 |
| Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure Heme Iron Polypeptide (Proferrin), Iron sucrose (Venofer) - Anemia, Renal Failure | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 55 | 2007-05-01 | 2016-05-10 |
Renal Insufficiency (15) · Anemia (1) · Critical Illness (1) · Fibrosis (1) · Heart Failure (1) · Hepatorenal Syndrome (1) · Hyponatremia (1) · Ischemia (1) · Kidney Failure, Chronic (1) · Multiple Myeloma (1) · Myocardial Infarction (1) · Renal Artery Obstruction (1) · Renal Insufficiency, Chronic (1) · Stroke (1)
Female Urogenital Diseases (15) · Female Urogenital Diseases and Pregnancy Complications (15) · Kidney Diseases (15) · Male Urogenital Diseases (15) · Urogenital Diseases (15) · Urologic Diseases (15) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Cardiovascular Diseases (4) · Disease Attributes (3) · Vascular Diseases (3) · Chronic Disease (2) · Heart Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2)
Tacrolimus (3) · Albumins (1) · Angioplasty (1) · Atorvastatin (1) · Calcium Dobesilate (1) · Colchicine (1) · Dexamethasone (1) · Ferric Oxide, Saccharated (1) · Imiquimod (1) · Lenalidomide (1) · Magnetic Resonance Spectroscopy (1) · Midodrine (1) · Natriuretic Peptide, Brain (1) · Saline Solution, Hypertonic (1)
Veloxis Pharmaceuticals (3) · University Health Network, Toronto (2) · Hamilton Health Sciences Corporation (1) · Hospital Clinic of Barcelona (1) · Humacyte, Inc. (1) · Jeffrey L. Lacy (1) · Ottawa Hospital Research Institute (1) · Region Skane (1) · The University of Hong Kong (1) · University of Alberta (1) · University of Florida (1) · University of Sao Paulo (1)
Canada (5) · United States (5) · Brazil (1) · Hong Kong (1) · Poland (1) · Spain (1) · Sweden (1)
Alan Glicklich, MD (1) · Charles K Stone, MD (1) · Deborah Zimmerman, MD (1) · Edimar A Bocchi, Professor (1) · Henrik Bjursten, M.D. Ph.D (1) · Ivan FN Hung, MD FRCP (1) · Jeffrey L Lacy, PhD (1) · Kong Teng Tan, BCh MB (1) · Michael Walsh, MD, PhD (1) · Rita Alloway, PharmD (1) · Shamik Shamik, MD (1) · Thomas Beaver, MD (1) · William Polvino, MD (1)
PMID 17992382, PMID 22243938, PMID 23514036, PMID 32476520, PMID 32556176, PMID 39878152